tiprankstipranks
Trending News
More News >
Integrum AB Class B (DE:6Y1)
:6Y1

Integrum AB Class B (6Y1) Price & Analysis

Compare
0 Followers

6Y1 Stock Chart & Stats


---

Financials

6Y1 FAQ

What was Integrum AB Class B’s price range in the past 12 months?
Integrum AB Class B lowest stock price was €1.15 and its highest was €5.14 in the past 12 months.
    What is Integrum AB Class B’s market cap?
    Integrum AB Class B’s market cap is €29.07M.
      When is Integrum AB Class B’s upcoming earnings report date?
      Integrum AB Class B’s upcoming earnings report date is Sep 01, 2025 which is in 118 days.
        How were Integrum AB Class B’s earnings last quarter?
        Currently, no data Available
        Is Integrum AB Class B overvalued?
        According to Wall Street analysts Integrum AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Integrum AB Class B pay dividends?
          Integrum AB Class B does not currently pay dividends.
          What is Integrum AB Class B’s EPS estimate?
          Integrum AB Class B’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Integrum AB Class B have?
          Integrum AB Class B has 20,694,328 shares outstanding.
            What happened to Integrum AB Class B’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Integrum AB Class B?
            Currently, no hedge funds are holding shares in DE:6Y1
            ---

            Company Description

            Integrum AB Class B

            Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Q-linea AB
            Acarix AB
            BrainCool AB
            Doxa AB
            Mentice AB
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis